FRANCESCHI, MARIA CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.330
AS - Asia 918
EU - Europa 686
SA - Sud America 100
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 3.067
Nazione #
US - Stati Uniti d'America 1.306
CN - Cina 415
SG - Singapore 300
IE - Irlanda 214
SE - Svezia 207
BR - Brasile 92
HK - Hong Kong 84
TR - Turchia 67
DE - Germania 62
NL - Olanda 46
FI - Finlandia 42
GB - Regno Unito 22
CI - Costa d'Avorio 20
CA - Canada 18
FR - Francia 18
RU - Federazione Russa 18
IT - Italia 17
IN - India 14
IR - Iran 7
RO - Romania 7
IL - Israele 6
BE - Belgio 5
EU - Europa 5
PL - Polonia 5
UA - Ucraina 5
MX - Messico 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
MA - Marocco 3
AR - Argentina 2
AZ - Azerbaigian 2
BD - Bangladesh 2
EC - Ecuador 2
JP - Giappone 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ES - Italia 1
GE - Georgia 1
HN - Honduras 1
ID - Indonesia 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 3.067
Città #
Chandler 354
Dublin 214
Singapore 184
Santa Clara 180
Ashburn 92
Hong Kong 84
Beijing 80
Dearborn 74
Nanjing 62
Shanghai 56
Izmir 54
Boardman 42
Princeton 42
Helsinki 34
Shenyang 32
Munich 30
Wilmington 26
Kunming 21
Abidjan 20
Hebei 20
Nanchang 20
Jiaxing 18
Los Angeles 18
San Mateo 18
Frankfurt am Main 16
Moscow 16
Changsha 13
Tianjin 12
Toronto 10
Ann Arbor 9
Columbus 9
Guangzhou 9
Kocaeli 9
Jinan 8
Turku 8
Dallas 7
Hefei 7
Pune 7
Augusta 6
Bremen 6
Fremont 6
Hangzhou 6
New York 6
Seattle 6
Timisoara 6
Brussels 5
Draper 5
Edinburgh 5
Grafing 5
London 5
Norwalk 5
Andover 4
Belo Horizonte 4
Bexley 4
Leawood 4
Parma 4
Phoenix 4
Taizhou 4
Wuhan 4
Brooklyn 3
Budapest 3
Cambridge 3
Fuzhou 3
Ningbo 3
Ottawa 3
Porto Alegre 3
Rio de Janeiro 3
Shijiazhuang 3
Stockholm 3
São Paulo 3
The Dalles 3
Uberlândia 3
Wroclaw 3
Zanjan 3
Ardabil 2
Baku 2
Bishkek 2
Borås 2
Brasília 2
Brno 2
Calgary 2
Castelnuovo Rangone 2
Chengdu 2
Chennai 2
Islamabad 2
Itaquaquecetuba 2
Jiangnong 2
Lanzhou 2
Las Vegas 2
Legnaro 2
Milan 2
Monmouth Junction 2
Mumbai 2
Patos de Minas 2
Praia Grande 2
Ribeirão Preto 2
Riga 2
Salvador 2
San Francisco 2
São Bernardo do Campo 2
Totale 2.116
Nome #
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 100
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 93
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 92
P.02.5: PPI Test for Diagnosis of Body Atrophic Gastritis: A Prospective Study 91
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 91
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 90
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 89
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 88
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 88
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 87
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 85
P.02.2: Improvement of Symptoms in Patients Affected by Chronic Athrophic Gastritis: A 2 Years Prospective Study by using L-Cysteine (Acetium™) 84
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test 81
The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people 80
P.02.10: Bismuth-Containing Quadruple Therapy in Patients Infected by Helicobacter Pylori: A First Real Life Italian Experience 79
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS 79
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases 78
P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population 78
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 76
P.07.2: Natural History of Symptomatic Uncomplicated Diverticular Disease: A 13-Year Prospective Study 73
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 73
P.14.3 A NON-INVASIVE MONITORING OF THE FUNCTIONALITY OF GASTRIC MUCOSA (GASTROPANEL TEST) IN DYSPEPTIC PATIENTS: A PRELIMINARY STUDY 73
Serum Pepsinogen II as a non-invasive marker for diagnosis of Helicobacter pylori infection: a prospective study in a cohort of dyspeptic patients 72
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS 71
P.04.3 SERUM PEPSINOGEN II LEVELS AND IGG ANTI HELICOBACTER PYLORI ANTIBODIES MAY REPRESENT A NON-INVASIVE METHOD FOR THE DIAGNOSIS AND MONITORING OF H PYLORI-RELATED GASTRITIS 70
P.02.19: Prevalence of H. Pylori Infection, Chronic Atrophic Gastritis and Reflux Disease in a Primary Care Population of North-East Italy with Serum Biomarker Panel (Gastropanel®) 70
Helicobacter pylori infection in asymptomatic elderly subjects living at home or in a nursing home: effects on gastric function and nutritional status 69
P.02.15: The Role of Gastropanel in the Evaluation of the Appropriateness of Proton PUMP Inhibitor (PPI)-Therapy Prescription in a Primary Care Population 69
P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients 69
P.16.3 IMPROVEMENT OF APPROPRIATENESS AND REDUCTION OF WAITING LISTS CONCERNING UPPER GI ENDOSCOPY OUTPATIENTS: A SINGLE-CENTRE PROSPECTIVE STUDY 68
The cure for Helicobacter pylori ((HP) infection with double or triple omeprazole-based therápies in the elderly: Effects on eradication rate, chronic gastritis and serum anti-HP antibodies and pepsinogens 68
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 67
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 67
Prevalence of H. pylori resistance to antibiotics in North-East Italy: A multicentered study 66
P.04.25 ROLE OF CYP2C19*17 AND CYP2C19*2 IN THE RESPONSE TO PROTON PUMP INHIBITORS TREATMENT IN PATIENTS WITH ESOPHAGITIS 62
Role of proton pump inhibitors in the prevention of upper GI bleeding in elderly acute and chronic NSAID users 61
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly 59
The effect of aging on oro-cecal transit time in normal subjects and patients with gallstone disease 53
La terapia delle malattie acido-correlate nell'anziano 51
P.17.5 UPPER GI BLEEDING: CLINICAL AND DEMOGRAPHIC FEATURES IN AN ENDOSCOPIC POPULATION STUDY OF NORTH-EAST ITALY 50
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 49
P.09.9 DIAGNOSTIC ACCURACY OF AGE AND ALARM SYMPTOMS FOR UPPER GI MALIGNANCY IN PATIENTS WITH DYSPEPSIA IN AN ENDOSCOPIC UNIT 41
null 10
Totale 3.110
Categoria #
all - tutte 12.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 6 0 1 1 0 1 6 9 28 0
2021/2022183 0 0 0 9 20 5 0 16 6 17 16 94
2022/2023924 72 114 68 93 58 122 1 84 273 3 32 4
2023/2024249 14 26 4 9 23 56 4 26 12 12 32 31
2024/20251.085 36 52 66 35 139 139 37 46 176 95 80 184
2025/202615 15 0 0 0 0 0 0 0 0 0 0 0
Totale 3.110